Novaliq | Evaluate

US FDA approval and panel tracker: June 2023

Go or no go? Key FDA decisions for Argenx and Regeneron

Pdufa dates are also set for Sarepta and UCB, and panels will discuss Leqembi and Beyfortus.

September 16, 2021

Aerie brushes off dry eye trial failure

Endpoints, schmendpoints.

April 14, 2021

Bausch boosted ahead of eye spin-off

NOV03 posts a pivotal win but the late-stage dry eye pipeline is crowded.